MAP2K7 and hepatocellular carcinoma: The phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin and the Raf/MEK/ERK signaling are the major mediators of several receptor tyrosine kinase pathways involved in HCC progression.